Pharmaceuticals in Indonesia

Pharmaceuticals in Indonesia

Code: ML-OHME4815 | Published: Dec-2015 | Pages: 35 | MarketLine
Price :
$350.00
USD

* Required Fields

$350.00

Details

Pharmaceuticals in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Indonesia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2014 annual average exchange rates.

- The Indonesian pharmaceuticals market had total revenues of $5.4bn in 2014, representing a compound annual growth rate (CAGR) of 10.4% between 2010 and 2014.

- The Indonesian market is still controlled by domestic companies that hold 70% of the market share compared to the 30% owned by multinationals.

- The performance of the market is forecast to decelerate, with an anticipated CAGR of 6.8% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $7.5bn by the end of 2019.

Key Findings
Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Indonesia

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Indonesia

Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Indonesia economy

Reasons To Buy
What was the size of the Indonesia pharmaceuticals market by value in 2014?

What will be the size of the Indonesia pharmaceuticals market in 2019?

What factors are affecting the strength of competition in the Indonesia pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Indonesias pharmaceuticals market?

Table of Contents

TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 20
PT Kalbe Farma Tbk 20
Novartis AG 23
Sanofi SA 27
Macroeconomic Indicators 30
Country Data 30
Methodology 32
Industry associations 33
Related MarketLine research 33
Appendix 34
About MarketLine 34

List of Tables
Table 1: Indonesia pharmaceuticals market value: $ billion, 2010-14
Table 2: Indonesia pharmaceuticals market geography segmentation: $ billion, 2014
Table 3: Indonesia pharmaceuticals market share: % share, by value, 2014
Table 4: Indonesia pharmaceuticals market value forecast: $ billion, 2014-19
Table 5: PT Kalbe Farma Tbk: key facts
Table 6: PT Kalbe Farma Tbk: key financials ($)
Table 7: PT Kalbe Farma Tbk: key financials (IDR)
Table 8: PT Kalbe Farma Tbk: key financial ratios
Table 9: Novartis AG: key facts
Table 10: Novartis AG: key financials ($)
Table 11: Novartis AG: key financial ratios
Table 12: Sanofi SA: key facts
Table 13: Sanofi SA: key financials ($)
Table 14: Sanofi SA: key financials (Euro)
Table 15: Sanofi SA: key financial ratios
Table 16: Indonesia size of population (million), 2010-14
Table 17: Indonesia gdp (constant 2005 prices, $ billion), 2010-14
Table 18: Indonesia gdp (current prices, $ billion), 2010-14
Table 19: Indonesia inflation, 2010-14
Table 20: Indonesia consumer price index (absolute), 2010-14
Table 21: Indonesia exchange rate, 2010-14

List of Figures
Figure 1: Indonesia pharmaceuticals market value: $ billion, 2010-14
Figure 2: Indonesia pharmaceuticals market geography segmentation: % share, by value, 2014
Figure 3: Indonesia pharmaceuticals market share: % share, by value, 2014
Figure 4: Indonesia pharmaceuticals market value forecast: $ billion, 2014-19
Figure 5: Forces driving competition in the pharmaceuticals market in Indonesia, 2014
Figure 6: Drivers of buyer power in the pharmaceuticals market in Indonesia, 2014
Figure 7: Drivers of supplier power in the pharmaceuticals market in Indonesia, 2014
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Indonesia, 2014
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Indonesia, 2014
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Indonesia, 2014
Figure 11: PT Kalbe Farma Tbk: revenues and profitability
Figure 12: PT Kalbe Farma Tbk: assets and liabilities
Figure 13: Novartis AG: revenues and profitability
Figure 14: Novartis AG: assets and liabilities
Figure 15: Sanofi SA: revenues and profitability
Figure 16: Sanofi SA: assets and liabilities
PT Kalbe Farma Tbk, Novartis AG, Sanofi SA

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.

CUSTOMERS WHO VIEWED THIS REPORT ALSO VIEWED

There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
MarketLine

Our Clients